CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
81 research outputs found
A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma
Author
Attal
El Accaoui
+27Â more
Facon
Harousseau
Hulin
Hus
Hye Jung Chang
Jae Hoon Lee
Jung-Lim Lee
Kim
Koh
Kyle
Lee
Myeloma Trialists' Collaborative Group
Palumbo
Phekoo
Qazilbash
San Miguel
Seung Hyun Nam
Singhal
Soo-Mee Bang
Steurer
Sung-Hwa Bae
Sung-Soo Yoon
Waage
Wijermans
Yakoub-Agha
Young Rok Do
Zonder
Publication venue
The Korean Association of Internal Medicine
Publication date
01/01/2011
Field of study
Get PDF
Crossref
PubMed Central
Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma
Author
A Sewing
Akihito Matsuoka
+43Â more
AL Gartel
BB Chen
CM Coticchia
CR Jan
D Donjerkovic
D Woods
DM Weber
DR Hodge
EY Ahn
H Ito
Hiroaki Dobashi
HM SchĂĽller
J Caers
J Choi
J Colomer
J Glassford
JC Chambard
JF San Miguel
K Balmanno
LO Dewhurst
M Bosch
M Taulés
MR Duchen
MW Berchtold
Myeloma Trialists’ Collaborative Group
N Juge-Morineau
N Katayama
NC Munshi
Osamu Imataki
P Gomez-Bougie
PM Fayers
R Burger
R Catlett-Falcone
S Elmore
S Lenhoff
S Ohkubo
Saki Yurimoto
Shigeyuki Yokokura
Shuji Bandoh
Takuya Matsunaga
V Dulić
WM Gregory
Z Wang
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Targeted therapy and maintenance in myeloma
Author
MarĂa-Victoria Mateos
Myeloma Trialists’ Collaborative Group
Verónica González-Calle
Publication venue
'Oxford University Press (OUP)'
Publication date
Field of study
No full text
Crossref
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group
Author
Barlogie B.
Fermand J.P.
+7Â more
Hjorth M.
Hjorth M.
Lenhoff S.
Myeloma Trialists' Collaborative Group
Nordic Myeloma Study Group.
Siegel D.S.
Wisloff F.
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Thalidomide-dexamethasone versus
Author
Abdelkefi
Attal
+15Â more
Barlogie
Brinker
Cunningham
Feyler
Fritz
Mihelic
Offidani
Offidani
Sahebi
Salmon
San-Miguel
Spencer
Stewart
The Myeloma Trialists’ Collaborative Group
Yakoub-Agha
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma
Author
Alexanian R.
Blade J.
+9Â more
Cox D.R.
Durie B.G.
Kaplan E.L.
Ludwig H.
Ludwig H.
Myeloma Trialists' Collaborative Group
Palmer M.
Peto R.
Salmon S.E.
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
Author
A Palumbo
BG Durie
+11Â more
C Hulin
F Gay
JF San Miguel
M Beksac
M Carrier
Myeloma Trialists Collaborative Group
P Kapoor
RA Kyle
SV Rajkumar
T Facon
The International Myeloma Working G
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Thalidomide: A Step Forward in the Treatment Malignant Monoclonal Gammopathies
Author
Alexanian
Alexanian
+19Â more
Avigdor
Barlogie
Barlogie
Bladé
Bladé
Bladé
Comenzo
Dimopoulos
Dimopoulos
Hideshima
Juliusson
Kneller
Kyle
Seldin
Singhal
Singhal
The Myeloma Trialists' Collaborative Group
Vacca
Yakoub-Agha
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Treatment of patients with multiple myeloma over 65Â yr: more tolerability or better response?
Author
Alexanian
Bird
+20Â more
Brenner
Cerrato
Dimopoulos
Durie
Fayers
Gay
Hulin
Kumar
Kumar
Kyle
Mateos
Myeloma Trialists’ Collaborative Group
Orlowski
Palumbo
Pulte
Rodon
San Miguel
Turesson
Van de Velde
Wijermans
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7
Author
Alexanian R.
Attal M.
+11Â more
Belch A.
Byar D.
Cox D.R.
Girling D.
Imrie K.
Mantel N.
Myeloma Trialists? Collaborative Group
Pater J.
Salmon S.E.
Shustik C.
Shustik C.
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
1
2
3
…
last